Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STANDARD BIOTOOLS INC. Director's Dealing 2011

Feb 17, 2011

32853_dirs_2011-02-17_642903db-200c-4fe1-b034-d270957488d8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2011-02-15

Reporting Person: COLELLA SAMUEL D (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-02-15 Common Stock C 5760 Acquired 87341 Indirect
2011-02-15 Common Stock C 1592 Acquired 88933 Indirect
2011-02-15 Common Stock C 103546 Acquired 192479 Indirect
2011-02-15 Common Stock C 474354 Acquired 666833 Indirect
2011-02-15 Common Stock C 294457 Acquired 961290 Indirect
2011-02-15 Common Stock C 81396 Acquired 1042686 Indirect
2011-02-15 Common Stock C 164 $0.02 Acquired 1042850 Indirect
2011-02-15 Common Stock C 346 $0.02 Acquired 1043196 Indirect
2011-02-15 Common Stock C 148 $0.02 Acquired 1043344 Indirect
2011-02-15 Common Stock C 7596 $0.02 Acquired 1050940 Indirect
2011-02-15 Common Stock X 8247 $0.02 Acquired 1059197 Indirect
2011-02-15 Common Stock F 11 $13.50 Disposed 1059186 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-02-15 Series C Preferred Stock $ C 5760 Disposed Common Stock (5760) Indirect
2011-02-15 Series D Preferred Stock $ C 1592 Disposed Common Stock (1592) Indirect
2011-02-15 Series E Preferred Stock $ C 103546 Disposed Common Stock (103546) Indirect
2011-02-15 Series B Preferred Stock $ C 474354 Disposed Common Stock (474354) Indirect
2011-02-15 Series C Preferred Stock $ C 294457 Disposed Common Stock (294457) Indirect
2011-02-15 Series D Preferred Stock $ C 81396 Disposed Common Stock (81396) Indirect
2011-02-15 Series E-1 Preferred Stock $ C 164 Disposed Common Stock (164) Indirect
2011-02-15 Series E-1 Preferred Stock $ C 346 Disposed Common Stock (346) Indirect
2011-02-15 Series E-1 Preferred Stock $ C 148 Disposed Common Stock (544) Indirect
2011-02-15 Series E-1 Preferred Stock $ C 7596 Disposed Common Stock (7596) Indirect
2011-02-15 Series E-1 Preferred Warrant (Right to Buy) $0.02 X 8257 Disposed Common Stock (8257) Indirect

Footnotes

F1: Represents shares of Common Stock issued upon conversion of shares of Series E Preferred Stock on a 1-for 1.300053676865 basis.

F2: Not applicable.

F3: Versant Affiliates Fund I-A, L.P., is the record holder of the securities reported.

F4: Voting and investment power over the shares directly held by Versant Venture Capital I, L.P., Versant Affiliates Fund I-A, L.P., Versant Affiliates Fund I-B, L.P., and Versant Side Fund I, L.P., is held by Versant Ventures I, LLC, their sole General Partner, Samuel D. Colella, the reporting person is a Managing Member of Versant Ventures I, LLC but he disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The individual Managing Members of Versant Ventures I, LLC are Brian G. Atwood, Samuel D. Colella, Ross A. Jaffe, William J. Link, Barbara N. Lubash, Donald B. Milder, and Rebecca B. Robertson, all of whom share voting and dispositive control. Each respective individual General Partner disclaims beneficial ownership of these shares, except to the extent of their pecuniary interest therein.

F5: Represents shares of Common Stock issued upon the conversion of shares of Series B Preferred Stock, Series C Preferred Stock or Series D Preferred Stock on a 1-for-1 basis.

F6: Versant Affiliates Fund I-B, L.P. is the record holder of the securities reported.

F7: Versant Side Fund I, L.P., is the record holder of the securities reported.

F8: Versant Venture Capital I, L.P., is the record holder of the securities reported.

F9: Each share of Series E Preferred Stock automatically converted into 1.300053676865 share of Common Stock on February 15, 2011, the closing date of the Issuer's initial public offering (the "Closing") and has no expiration date.

F10: The Colella Family Trust U/D/T dated September 21, 1992 is the record holder of the securities reported. Samuel D. Colella and Nancy R. Colella are trustees of the Colella Family Trust U/D/T dated September 21, 1992.

F11: Each share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock or Series E-1 Preferred Stock automatically converted into one share of Common Stock on February 15, 2011 and has no expiration date.

F12: The warrant was automatically net exercised immediately prior to the Closing.